118 results
Page 3 of 6
POSASR
eq9hx2hn1r zbtm4o
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am
8-K
EX-99.1
0qe07
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
EX-99.1
3rnca2p
4 Feb 22
Orchard Therapeutics Announces Historic Agreement Making Libmeldy® Available by NHS England for MLD Patients
7:00am
8-K
EX-99.1
f687ha
21 Jan 22
Other Events
7:05am
8-K
EX-99.1
pdnavr
10 Jan 22
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
7:05am
8-K
EX-99.2
x50u530rmfnwavisa
10 Jan 22
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
7:05am
8-K
EX-99.1
h6n rsb7wvztqr2t
4 Nov 21
Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates
7:50am
8-K
EX-99.1
b4i6s swhinq
14 Sep 21
Other Events
4:29pm
S-8
EX-5.1
zlmelkai3thu5oomf
4 Aug 21
Registration of securities for employees
4:06pm
8-K
EX-99.1
9qquf0yaznqm4c42bb
4 Aug 21
Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Updates
7:05am
8-K
EX-99.1
kpm1r8ek 3qz
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
EX-99.1
8p1rqbzmy4 3gouz9b
29 Jun 21
Orchard Therapeutics Announces Regulatory and Clinical Updates for Lead Gene Therapy Programs
7:05am
8-K
EX-99.1
8pqbzzcdg
13 May 21
Orchard Therapeutics Reports First Quarter 2021 Financial Results and Provides Recent Business Updates
7:05am
S-3ASR
5wpigh7o9
8 Apr 21
Automatic shelf registration
4:11pm